BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37012127)

  • 1. Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.
    Cimsit C; Kursun M; Demircioglu O; Dilber F; Demirtas CO; Ergenc I
    Acad Radiol; 2023 Sep; 30 Suppl 1():S124-S131. PubMed ID: 37012127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
    Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.
    Asghar MS; Ahsan MN; Rasheed U; Hassan M; Jawed R; Abbas MB; Yaseen R; Ali Naqvi SA; Rizvi H; Syed M
    Cureus; 2020 Dec; 12(12):e12294. PubMed ID: 33520498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.
    Tachi Y; Kozuka A; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    Nutrition; 2018 Oct; 54():83-88. PubMed ID: 29753174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
    Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
    World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.
    Hara N; Iwasa M; Sugimoto R; Mifuji-Moroka R; Yoshikawa K; Terasaka E; Hattori A; Ishidome M; Kobayashi Y; Hasegawa H; Iwata K; Takei Y
    Intern Med; 2016; 55(8):863-70. PubMed ID: 27086797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Yip TC; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW; Wong GL
    Am J Gastroenterol; 2018 Nov; 113(11):1629-1638. PubMed ID: 30315283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.
    Van Roey G; Fevery J; Van Steenbergen W
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):61-6. PubMed ID: 10656212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis.
    Ha NB; Montano-Loza AJ; Carey EJ; Lin S; Shui AM; Huang CY; Dunn MA; Lai JC
    Am J Transplant; 2022 Sep; 22(9):2195-2202. PubMed ID: 35486028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoas muscle index predicts time to rehospitalization in liver cirrhosis: An observational study.
    Hentschel F; Schwarz T; Lüth S; Schreyer AG
    Medicine (Baltimore); 2022 Sep; 101(36):e30259. PubMed ID: 36086704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.
    Hiraoka A; Michitaka K; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Yamago H; Suga Y; Tomida H; Miyamoto Y; Azemoto N; Mori K; Miyata H; Tsubouchi E; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):940-7. PubMed ID: 27232361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
    Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
    Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.